Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences

Area of Science:

• Cardiology
• Metabolic Health
• Preventive Medicine

Background:

• Prehypertension, defined by specific blood pressure ranges, signifies an elevated risk for cardiovascular disease.
• It is a critical component of cardiometabolic syndrome, alongside obesity, dyslipidemia, and prediabetes.
• Early identification of cardiovascular disease in asymptomatic individuals is crucial for tailored preventive strategies.

Purpose of the Study:

• To highlight prehypertension as a continuum to hypertension and a risk factor for cardiovascular disease.
• To emphasize the role of lifestyle interventions and component treatment in managing cardiometabolic syndrome.
• To underscore the importance of early cardiovascular disease detection for individualized preventive therapy.

Main Methods:

• Review of existing studies on dietary approaches for hypertension and metabolic conditions.
• Observation of ongoing large trials investigating antihypertensive drugs.
• Analysis of methods for identifying early cardiovascular disease in asymptomatic populations.

Main Results:

• Dietary interventions have demonstrated efficacy in halting hypertension progression and improving metabolic health.
• Antihypertensive drug trials aim to delay the onset of hypertension.
• Early cardiovascular disease detection offers superior guidance for preventive therapy over traditional risk assessment.

Conclusions:

• Prehypertension necessitates proactive management due to its link with cardiovascular disease and cardiometabolic syndrome.
• Lifestyle modifications and targeted treatments are vital for preventing hypertension and improving metabolic profiles.
• Individualized preventive therapy guided by early cardiovascular disease detection is more effective than traditional risk factor assessment.